AND017 Cancer Related Anemia (CRA) - Phase II study NMPA IND approval

AND019-Phase I study  NMPA IND approval

AND019 – Phase I study FDA IND approval

AND017 – Phase II study China central IRB approval

AND017 – Phase II study FDA IND approval

AND017 – China Phase I study complete

Ground broken on a 200,000 square foot administrative office space and manufacturing facility in Hangzhou

AND017 – Australia Phase I study complete

"Innovative Entrepreneurship Team of Zhejiang Province" award

Nobel Prize of Physiology or Med awarded to the MoA of AND017

AND019 – Initiation of IND enabling study

AND017 – China Phase I study IND approval

12.5 million non-dilutive grant awarded by Yuhang Industrial Fund

AND017 – Patent filed in China

R&D Initiation

Founded at Yuhang District, Hangzhou